MERRIMACK PHARMACEUTICALS INC Debt Securities, Held-to-maturity, Current
MERRIMACK PHARMACEUTICALS INC had Debt Securities, Held-to-maturity, Current of $9.95 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments › Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Current
us-gaap:HeldToMaturitySecuritiesCurrent · last filed 2024-05-15
- 2024-03-31: Debt Securities, Held-to-maturity, Current $9.95M.
- 2023-12-31: Debt Securities, Held-to-maturity, Current $12.89M.
- 2023-09-30: Debt Securities, Held-to-maturity, Current $12.82M.
- 2023-06-30: Debt Securities, Held-to-maturity, Current $8.84M.
| Period end | Debt Securities, Held-to-maturity, Current |
|---|---|
| 2024-03-31 | $9.95M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $12.89M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $12.82M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $8.84M 10-Q · filed 2023-08-03 |